Multimodality Treatment and Long-Term Follow–Up of the Primary Pulmonary Lymphoepithelioma-Like Carcinoma

2012 ◽  
Vol 13 (5) ◽  
pp. 359-362 ◽  
Author(s):  
Chung-Jen Huang ◽  
An-Chen Feng ◽  
Yueh-Fu Fang ◽  
Wen-Hui Ku ◽  
Nei-Min Chu ◽  
...  
Skull Base ◽  
2007 ◽  
Vol 17 (S 2) ◽  
Author(s):  
Sabareesh Natarajan ◽  
Laligam Sekhar ◽  
David Schessel ◽  
Akio Morita

1992 ◽  
Vol 106 (3) ◽  
pp. 234-237 ◽  
Author(s):  
A. Klima ◽  
I. Bergmann ◽  
S. Szepesi

AbstractWe treated 114 patients with advanced inoperable head and neck cancer with a combined-modality protocol that included two cycles of chemotherapy followed by radiotherapy or three cycles of chemotherapy and in 18 patients with a radiosensitizing agent. At the beginning of the treatment all but one patient presented with a stage IV cancer. With a follow-up of 42–58 months, four patients are alive (three from the radiosensitizing group and one of the chemotherapy group). Complete response after the radiosensitizing agent correlated with superior prolonged disease-free survival in comparison to complete responses after chemotherapy at the level of p<0.009.


2019 ◽  
Vol 42 ◽  
Author(s):  
John P. A. Ioannidis

AbstractNeurobiology-based interventions for mental diseases and searches for useful biomarkers of treatment response have largely failed. Clinical trials should assess interventions related to environmental and social stressors, with long-term follow-up; social rather than biological endpoints; personalized outcomes; and suitable cluster, adaptive, and n-of-1 designs. Labor, education, financial, and other social/political decisions should be evaluated for their impacts on mental disease.


2001 ◽  
Vol 120 (5) ◽  
pp. A397-A397
Author(s):  
M SAMERAMMAR ◽  
J CROFFIE ◽  
M PFEFFERKORN ◽  
S GUPTA ◽  
M CORKINS ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A204-A204
Author(s):  
B GONZALEZCONDE ◽  
J VAZQUEZIGLESIAS ◽  
L LOPEZROSES ◽  
P ALONSOAGUIRRE ◽  
A LANCHO ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document